Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma

Genes Chromosomes and Cancer

Volumn 51, Issue 8, 2012, Pages 792-804

  Cournoyer, Sonia ^a,b   Nyalendo, Carine ^a,b   Addioui, Anissa ^a,b   Belounis, Assila ^a,b   Beaunoyer, Mona ^a   Aumont, Anne ^b   Teira, Pierre ^a   Duval, Michel ^a   Fernandes, Karl ^b   Fetni, Raouf ^a,b   Haddad, Elie ^a,b   Sartelet, Hervé ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CD133 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL ISOLATION; CELL POPULATION; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GENE;

ADRENAL GLAND NEOPLASMS; ANIMALS; ANTIGENS, CD; CELL LINE, TUMOR; CELL SEPARATION; CHI-SQUARE DISTRIBUTION; CHROMOSOME ABERRATIONS; FEMALE; GENOTYPE; GLYCOPROTEINS; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MUTAGENESIS, INSERTIONAL; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE;

MUS;

EID: 84861678708     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.21964     Document Type: Article

References (47)

1. Aasheim HC, Pedeutour F, Grosgeorge J, Logtenberg T. 1998. Cloning, chromosal mapping, and tissue expression of the gene encoding the human Eph-family kinase ligand ephrin-A2. Biochem Biophys Res Commun 252: 378-382.
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. 2003. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988.
3. Artero-Castro A, Callejas FB, Castellvi J, Kondoh H, Carnero A, Fernández-Marcos PJ, Serrano M, Ramón y Cajal S, Lleonart ME. 2009. Cold-inducible RNA-binding protein bypasses replicative senescence in primary cells through extracellular signal-regulated kinase 1 and 2 activation. Mol Cell Biol 29: 1855-1868.
4. Baiocchi M, Biffoni M, Ricci-Vitiani L, Pilozzi E, De Maria R. 2010. New models for cancer research: Human cancer stem cell xenografts. Curr Opin Pharmacol 10: 380-384.
5. Borst, P, Evers R, Kool M, Wijnholds J. 1999. The multidrug resistance protein family. Biochim Biophys Acta 1461: 347-357.
6. Bortfeld M, Rius M, König J, Herold-Mende C, Nies AT, Keppler D. 2006. Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience 137: 1247-1257.
7. Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL, Tsiatis AA. 1981. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41: 4678-4686.
8. Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI. 1988. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6: 1874-1881.
9. Carr J, Bown NP, Case MC, Hall AG, Lunec J, Tweddle DA. 2007. High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays. Cancer Genet Cytogenet 172: 127-138.
10. Dalerba P, Cho RW, Clarke MF. 2007. Cancer stem cells: Models and concepts. Annu Rev Med 58: 267-284.
11. Davenport RW, Thies E, Zhou R Nelson PG. 1998. Cellular localization of ephrin-A2, ephrin-A5, and other functional guidance cues underlies retinotopic development across species. J Neurosci 18: 975-986.
12. Feng YX, Zhao JS, Li JJ, Wang T, Cheng SQ, Yuan Y, Wang F, Wang XF, Xie D. 2010. Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway 120:. Hepatology 51: 535-544.
13. Fox BP, Kandpal RP. 2004. Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. Biochem Biophys Res Commun 318: 882-892.
14. Frank NY, Schatton T, Frank MH. 2010. The therapeutic promise of the cancer stem cell concept. J Clin Invest 120: 41-50.
15. Gaiser T, Camps J, Meinhardt S, Wangsa D, Nguyen QT, Varma S, Dittfeld C, Kunz-Schughart LA, Kemmerling R, Becker MR, Heselmeyer-Haddad K, Ried T. 2011. Genome and transcriptome profiles of CD133-positive colorectal cancer cells. Am J Pathol 178: 1478-1488.
16. Gavin EJ, Song B, Wang Y, Xi Y, Ju J. 2008. Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatin. PLoS One 3: e4054.
17. Genander M, Frisén J. 2010. Ephrins and Eph receptors in stem cells and cancer. Curr Opin Cell Biol 22: 611-616.
18. Gilbert F, Balaban G, Moorhead P, Bianchi D, Schlesinger H. 1982. Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet Cytogenet 7: 33-42.
19. George, RE, Attiyeh, EF, Li, S, Moreau, LA, Neuberg, D, Li, C, Fox, EA, Meyerson, M, Diller, L, Fortina, P, Look, AT, Maris, JM. 2007. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays. PLoS One 2: e255.
20. Guo Y, Köck K, Ritter CA, Chen ZS, Grube M, Jedlitschky G, Illmer T, Ayres M, Beck JF, Siegmund W, Ehninger G, Gandhi V, Kroemer HK, Kruh GD, Schaich, M. 2009. Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival. Clin Cancer Res 15: 1762-1769.
21. Hamburger AW, Salmon SE. 1977. Primary bioassay of human tumor stem cells. Science 197: 461-463.
22. Ishola TA, Chung DH. 2007. Neuroblastoma Surg Oncol 16: 149-156.
23. Jordan CT, Guzman ML, Noble M. 2006. Cancer stem cells. N Engl J Med 355: 1253-1261.
24. Killian A, Le Meur N, Sesboüé R, Bourguignon J, Bougeard G, Gautherot J, Bastard C, Frébourg T, Flaman J. M. 2004. Inactivation of the RRB1-Pescadillo pathway involved in ribosome biogenesis induces chromosomal instability. Oncogene 23: 8597-8602.
25. Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396: 643-649.
26. Li Y, Li A, Glas M, Lal B, Ying M, Sang Y, Xia S, Trageser D, Guerrero-Cázares H, Eberhart CG, Quiñones-Hinojosa A, Scheffler B, Laterra J. 2011. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc Natl Acad Sci USA 108: 9951-9956.
27. Lleonart ME. 2010. A new generation of proto-oncogenes: Cold-inducible RNA binding proteins. Biochim Biophys Acta 1805: 43-52.
28. London WB, Castleberry R., Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL. 2005. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol 23: 6459-6465.
29. Mahller YY, Williams JP, Baird WH, Mitton B, Grossheim J, Saeki Y, Cancelas JA, Ratner N, Cripe TP. 2009. Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus. PLoS One 4: e4235.
30. Maris JM. 2005. The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr 17: 7-13.
31. Maris JM. 2010. Recent advances in neuroblastoma. N Engl J Med 362: 2202-2211.
32. Modak S, Cheung NK. 2010. Neuroblastoma: Therapeutic strategies for a clinical enigma. Cancer Treat Rev 36: 307-317.
33. Mullassery D, Dominici C, Jesudason EC, McDowell HP, Losty PD. 2009. Neuroblastoma: Contemporary management. Arch Dis Child Educ Pract Ed 94: 177-185.
34. Nishiyama H, Higashitsuji H, Yokoi H, Itoh K, Danno S, Matsuda T, Fujita J. 1997. Cloning and characterization of human CIRP (cold-inducible RNA-binding protein) cDNA and chromosomal assignment of the gene. Gene 204: 115-120.
35. Pastrana E, Silva-Vargas V, Doetsch F. 2011. Eyes wide open: A critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 8: 486-498.
36. Perez CA, Matthay KK, Atkinson JB, Seeger RC, Shimada H, Haase GM, Stram DO, Gerbing RB, Lukens JN. 2000. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: A children's cancer group study. J Clin Oncol 18: 18-26.
37. Prasanth SG, Prasanth KV, Stillman B. 2002. Orc6 involved in DNA replication, chromosome segregation, and cytokinesis. Science 297: 1026-1031.
38. Saito K, Fukuda N, Matsumoto T, Iribe Y, Tsunemi A, Kazama T, Yoshida-Noro C, Hayashi N. 2010. Moderate low temperature preserves the stemness of neural stem cells and suppresses apoptosis of the cells via activation of the cold-inducible RNA binding protein. Brain Res 1358: 20-29.
39. Schiapparelli P, Enguita-Germán M, Balbuena J, Rey JA, Lázcoz P, Castresana JS. 2010. Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines. Oncol Rep 24: 1355-1362.
40. Seaberg RM, Van der Kooy D. 2003. Stem and progenitor cells: The premature desertion of rigorous definitions. Trends Neurosci 26: 125-131.
41. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. 2004. Identification of human brain tumour initiating cells. Nature 432: 396-401.
42. Takenobu H, Shimozato O, Nakamura T, Ochiai H, Yamaguchi Y, Ohira M, Nakagawara A, Kamijo T. 2011. CD133 suppresses neuroblastoma cell differentiation via signal pathway modification. Oncogene 30: 97-105.
43. Visvader JE, Lindeman GJ. 2008. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
44. Volchenboum SL, Li C, Li S, Attiyeh EF, Reynolds CP, Maris JM, Look AT, George RE. 2009. Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis. Cancer Res 69: 4143-4149.
45. Ward RJ, Dirks PB. 2007. Cancer stem cells: at the headwaters of tumor development. Annu Rev Pathol 2: 175-189.
46. Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM, Group C.s.O. 2010. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 363: 1324-1334.
47. Zeng Y, Kulkarni P, Inoue T, Getzenberg RH. 2009. Down-regulating cold shock protein genes impairs cancer cell survival and enhances chemosensitivity. J Cell Biochem 107: 179-188.